Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Eli Lilly to Pay $62 Million in Zyprexa Settlement
Link ID 9453
Title Eli Lilly to Pay $62 Million in Zyprexa Settlement
Url http://www.medscape.com/viewarticle/581730?src=rss
Description Eli Lilly and Co has agreed to pay $62 million to settle claims that it improperly marketed its top-selling Zyprexa schizophrenia drug to patients who were not approved users, the company said on Tuesday. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Oct 9, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Performance Measurement and Improvement Frameworks in Health, Education and Social Services Systems:
  This comprehensive review finds a wide volume and breadth of work focused on the development of frameworks for performance and quality improvement purposes. International Journal for Quality in Health Care
Category:   Articles > Business of Medicine


2. Natalizumab Associated With Ongoing Cases of PML
  Rare but ongoing cases of PML continue to be associated with the use of natalizumab, according to the FDA. Medscape Medical News
Category:   Articles > Business of Medicine


3. Part 2: A Reader and Author Respond to "Esoteric or Exoteric? Music in Medicine"
  A reader and author discuss researching music and its effects.
The Medscape Journal of Medicine
Category:   Articles > Business of Medicine


4. Cases from AHRQ WebM&M: Deaths Not Foretold: Are Unexpected Deaths Useful Patient Safety Signals?
  When a patient dies, are low-mortality DRGs valid indicators of patient safety problems? Agency for Healthcare Research and Quality (AHRQ)
Category:   Articles > Business of Medicine


5. Almost 20% of Stroke Drug Trials Never Published in Full
  A review concludes that nearly 20% of completed trials of drug treatment for acute stroke are not ultimately published, but experts debate the relevance of this finding. Medscape Medical News
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS